The Food and Drug Administration is projecting a more favorable stance toward biotech, emphasizing streamlined processes and accelerated approvals (“FDA Sends a Bullish Signal to Biotech ...

Rather, with so much uncertainty, investors are prizing biotech companies that base their intellectual property and manufacturing in the U.S., which up until now often meant higher taxes.

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

Biotech mogul Sam Waksal – who landed in prison two decades ago over the ImClone insider trading scandal that also resulted in jail time for Martha Stewart – allegedly tested an illegal ...

In biotechnology, precision, iteration and aligned resources are all critical drivers of breakthroughs in gene therapy. I think these same principles can be fundamental for success in other ...

By Deena Beasley (Reuters) -Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest in a string of drugmakers pledging to increase U.S ...

George Yancopoulos, co-founder of biotech company Regeneron, has purchased almost all of the condominium units in a mixed-use Tribeca building, according to city records made public this week.

The Department of Health and Human Services (HHS) has lifted a stop work order on Vaxart’s phase 2b trial testing out an investigational COVID-19 vaccine pill, with the biotech resuming plans to ...

Today, almost all available birth control options are female contraceptives. Biotech company Contraline, however, claims that clinical trials for its non-hormonal and reversible male contraceptive ...

An age-old question about which came first, the chicken or the egg, won't matter for a biotech startup that aims to make egg protein powder — used in baked goods and other foods — from ...

Kane Biotech's December 31, 2024 Financial Statements and the Management Discussion and Analysis with regards thereto are now available on SEDAR+ and the Company's website. Management believes that ...

German drug company Merck KGaA said Monday it has struck a deal to buy U.S. biotech firm SpringWorks Therapeutics for around $3.9 billion, expanding its portfolio of rare disease and cancer ...